$33.35
0.30% today
Nasdaq, Sep 23, 04:41 pm CET
ISIN
US45258D1054
Symbol
IMCR

Immunocore Holdings plc - ADR Stock News

Neutral
Seeking Alpha
13 days ago
Immunocore Holdings plc (NASDAQ:IMCR ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 1:50 PM EDT Company Participants Travis Coy - CFO, Executive VP & Head of Corporate Development Conference Call Participants Sean Laaman - Morgan Stanley, Research Division Presentation Sean Laaman Head of Healthcare Research & Equity Analyst Good afternoon, everyone, and welcome to...
Neutral
GlobeNewsWire
19 days ago
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md.
Neutral
Seeking Alpha
about 2 months ago
Immunocore Holdings plc (NASDAQ:IMCR ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants & - Corporate Participant Bahija Jallal - CEO & Executive Director Clayton Robertson - Head of Investor Relations David Berman - Executive Vice President of Research Development Mohammed M. Dar - Senior VP of Clinical Development & Chief Medical Officer Ralph Torbay - Corporate...
Positive
The Motley Fool
about 2 months ago
Immunocore Plc (IMCR 0.06%), a biotechnology company specializing in T cell receptor therapies, reported its second quarter 2025 results on August 7, 2025. The main headline was a solid revenue increase, with $98.0 million (GAAP) surpassing consensus estimates of $92.15 million.
Neutral
GlobeNewsWire
about 2 months ago
KIMMTRAK ® (tebentafusp-tebn) net revenues of $98.0 million in Q2 2025, growing by 30% year-over-year
Neutral
GlobeNewsWire
about 2 months ago
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md.
Neutral
GlobeNewsWire
3 months ago
RIYADH, Saudi Arabia and ISTANBUL and OXFORDSHIRE, United Kingdom, June 30, 2025 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced that they have been appointed by Immunocore (Nasdaq: IMCR) as the distribution and commercialization partner for KIMMTRAK, for the treatment of HLA-A*02:01-positive adults wi...
Neutral
GlobeNewsWire
4 months ago
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today